North America In-vitro Diagnostics Market to witness 5.6%+ CAGR by 2024

1

North America In-vitro Diagnostics Market to
reach USD 39bn by 2024 Graphical Research
2018 Graphical Research. All rights
reserved.


www.graphicalresearch.com
2

Key Insights from North America In-vitro
Diagnostics Market

• Graphical Research says, North America In-vitro
  Diagnostics Market to reach USD 39bn by 2024
• Integration of advanced technology within the
  diagnostic devices will improve accuracy and
  efficiency of these devices that should have a
  positive impact on in-vitro diagnostics industry
  growth.
• Technologically advanced countries such as the
  U.S. and Canada focus their efforts on RD to
  manufacture automated laboratory diagnostic
  machines and equipment for accurate detection of
  diseases.
• In-vitro diagnostics market should grow
  significantly as a result of increasing
  prevalence of chronic diseases such as diabetes
  and cancer. As reported by National Cancer
  Institute, in 2018, there will be 1,735,350 cases
  of cancer that will escalate the business growth
  significantly in the near future.
• Reagents kits segment will grow at 6.6 during
  the forecast timeframe owing to escalating demand
  for such product types used in diagnosis of
  viral, fungal and bacterial diseases.

2018 Graphical Research. All rights
reserved.


www.graphicalresearch.com
3

Continued...

• Data management software segment accounted for
  20.7 revenue share in 2017.
• Molecular diagnostics technology segment will
  grow at 8.3 CAGR over the forecast timeframe.
• Diabetes segment was valued at USD 3.9 billion in
  2017 and is expected to have high growth rate as
  a result of growing prevalence of diabetes in
  developed countries due to increasing incidences
  of obesity amongst the individuals.
• Point-of-care segment had enormous market size of
  USD 6.2 billion in 2017 and the high growth of
  the segment can be accounted to the growing use
  of point-of care molecular diagnostic devices for
  detecting blood glucose levels even at home.
• U.S. in-vitro diagnostics market should witness
  high growth and held a momentous share of USD
  23.9 billion.
• Key industry competitors operating in North
  America in-vitro diagnostics market are Abbott,
  Becton Dickinson, BioRad, BioMerieux, Cephied,
  Danaher, Grifols, Johnson Johnson, Luminex,
  Roche Diagnostics, Siemens, Sorin, Thermo Fisher
  and Qiagen.

2018 Graphical Research. All rights
reserved.


www.graphicalresearch.com
4

Browse Full Market Research Report On North
America In-vitro Diagnostics Market _at_
https//bit.ly/2NUnZTf Request for a Sample
of this Research Report _at_ https//bit.ly/2PepUhM

2018 Graphical Research. All rights
reserved.


www.graphicalresearch.com
5

Stay In Touch With Us For
Website www.graphicalresearch.com Socia
l Media
Assured Quality
On-Time Delivery
Industry Experts
Payment Security
2018 Graphical Research. All rights
reserved.


www.graphicalresearch.com